相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The molecular pharmacology of AMD11070: An orally bioavailable CXCR4 HIV entry inhibitor
Renee M. Mosi et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Insight into the Structural Requirements of Narlaprevir-Type Inhibitors of NS3/NS4A Protease Based on HQSAR and Molecular Field Analyses
Jingyu Zhu et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2012)
Studies on the Interactions between β2 Adrenergic Receptor and Gs Protein by Molecular Dynamics Simulations
Zhiwei Feng et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Characterization of Domain-Peptide Interaction Interface: Prediction of SH3 Domain-Mediated Protein-Protein Interaction Network in Yeast by Generic Structure-Based Models
Tingjun Hou et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Structure of the First Sphingosine 1-Phosphate Receptor
Abby L. Parrill et al.
SCIENCE SIGNALING (2012)
Crystal structure of the β2 adrenergic receptor-Gs protein complex
Soren G. F. Rasmussen et al.
NATURE (2011)
Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents
John F. Miller et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Novel Monocyclam Derivatives as HIV Entry Inhibitors: Design, Synthesis, Anti-HIV Evaluation, and Their Interaction with the CXCR4 Co-receptor
Sofia Pettersson et al.
CHEMMEDCHEM (2010)
Ligand-guided optimization of CXCR4 homology models for virtual screening using a multiple chemotype approach
Marco A. C. Neves et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2010)
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Beili Wu et al.
SCIENCE (2010)
The Past, Present, and Future of HIV Prevention: Integrating Behavioral, Biomedical, and Structural Intervention Strategies for the Next Generation of HIV Prevention
Mary Jane Rotheram-Borus et al.
ANNUAL REVIEW OF CLINICAL PSYCHOLOGY (2009)
Pharmacology of AMD3465: A small molecule antagonist of the chemokine receptor CXCR4
Veronique Bodart et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Photolabeling identifies transmembrane domain 4 of CXCR4 as a T140 binding site
Philip E. Boulais et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Amine substituted N-(1H-benzimidazol-2ylmethyl)-5,6,7,8-tetrahydro-8-quinolinamines as CXCR4 antagonists with potent activity against HIV-1
Kristjan S. Gudmundsson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Proof of Activity with AMD11070, an Orally Bioavailable Inhibitor of CXCR4-Tropic HIV Type 1
Graeme Moyle et al.
CLINICAL INFECTIOUS DISEASES (2009)
New developments in HIV drug resistance
Patricia A. Cane
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Small Molecules Anti-HIV Therapeutics Targeting CXCR4
Nouri Neamati et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Orally Bioavailable Isothioureas Block Function of the Chemokine Receptor CXCR4 In Vitro and In Vivo
Gebhard Thoma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Comparison of the Potential Multiple Binding Modes of Bicyclam, Monocylam, and Noncyclam Small-Molecule CXC Chemokine Receptor 4 Inhibitors
Rebecca S. Y. Wong et al.
MOLECULAR PHARMACOLOGY (2008)
Crystal structure of squid rhodopsin
Midori Murakami et al.
NATURE (2008)
Crystal structure of the ligand-free G-protein-coupled receptor opsin
Jung Hee Park et al.
NATURE (2008)
The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist
Veli-Pekka Jaakola et al.
SCIENCE (2008)
High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor
Vadim Cherezov et al.
SCIENCE (2007)
GPCR engineering yields high-resolution structural insights into β2-adrenergic receptor function
Daniel M. Rosenbaum et al.
SCIENCE (2007)
Molecular mechanism of action of Monocyclam versus Bicyclam non-peptide antagonists in the CXCR4 chemokine receptor
Mette M. Rosenkilde et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Prediction of the 3D structure and dynamics of human DP G-protein coupled receptor bound to an agonist and an antagonist
Youyong Li et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Broad HIV-1 neutralization mediated by CD4-binding site antibodies
Yuxing Li et al.
NATURE MEDICINE (2007)
Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: Mechanism for binding and drug resistance
Tingjun Hou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection
Hendrik Streeck et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events
HT Ho et al.
JOURNAL OF VIROLOGY (2006)
HIV entry inhibitors: mechanisms of action and resistance pathways
V Briz et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1α on CXCR4 transmembrane helical domains
SM Tian et al.
JOURNAL OF VIROLOGY (2005)
AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor
S Hatse et al.
BIOCHEMICAL PHARMACOLOGY (2005)
VEGA - An open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming
A Pedretti et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2004)
Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor - Transfer of binding site to the CXCR3 receptor
MM Rosenkilde et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions
Q Guo et al.
JOURNAL OF VIROLOGY (2003)
Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL
P Staller et al.
NATURE (2003)
A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding
PF Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The entry of entry inhibitors: A fusion of science and medicine
JP Moore et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Novel therapies based on mechanisms of HIV-1 cell entry
JM Kilby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies
TJ Hou et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2003)
Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies
NM Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
An improved empirical potential energy function for molecular simulations of phospholipids
SE Feller et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2000)
Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities
A Brelot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers
CW Hendrix et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
